Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
about
Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screeningBiomaterials for pluripotent stem cell engineering: From fate determination to vascularization.Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines.
P2860
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
@en
type
label
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
@en
prefLabel
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
@en
P2860
P1476
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening
@en
P2093
David J Milan
Jordan S Leyton-Mange
P2860
P2888
P356
10.1007/S11936-014-0334-1
P577
2014-09-01T00:00:00Z